呼延坤
Lv41
470 积分
2022-06-24 加入
-
Trends in small molecule drug properties: Adevelopability molecule assessmentperspective
26天前
已完结
-
Amplification of autoimmune organ damage by NKp46-activated ILC1
28天前
已完结
-
TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
1个月前
已完结
-
Exploring new perspectives in immunology
1个月前
已完结
-
Autoimmune diseases: targets, biology, and drug discovery
2个月前
已完结
-
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
2个月前
已完结
-
Autoimmune Disease Treatment Market Size, Share, Growth, and Industry Analysis, By Type (Immunosuppressant’s, Anti-Inflammatory Drugs, Corticosteroids, Nonsteroidal Anti-inflammatory Drugs, Biologics), By Application (Hospitals, Clinics, Drug Stores, Other), Regional Insights, and Forecast To 2032
2个月前
已关闭
-
Sequential immunotherapy: towards cures for autoimmunity
2个月前
已完结
-
Inhibition of Cyclic GMP-AMP Synthase Using a Novel Antimalarial Drug Derivative in Trex1-Deficient Mice
2个月前
已完结
-
Expression of Cyclic GMP-AMP Synthase in Patients With Systemic Lupus Erythematosus
2个月前
已完结